Rectal cancer treatment has evolved during the past 40 years with the use of a standardized
surgical technique for tumour resection: total mesorectal excision. A dramatic reduction in …

Transanal total mesorectal excision (taTME) has evolved over the past decade fueled by
advances in minimally invasive surgery. The technique aims to overcome the constraints …

This selection from the NCCN Guidelines for Rectal Cancer focuses on management of
malignant polyps and resectable nonmetastatic rectal cancer because important updates …

The incidence of rectal cancer in the European Union is $125 000 per year, ie $35% of the
total colorectal cancer incidence, reflecting 15–25 cases/100000 population per year and is …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer
address diagnosis, staging, surgical management, perioperative treatment, management of …

Background Induction of a clinical complete response with chemoradiotherapy, followed by
observation via a watch-and-wait approach, has emerged as a management option for …

Objective: The aim of this study was to evaluate the oncological and survival outcomes of a
Watch and Wait policy in rectal cancer after a clinical complete response (cCR) following …

Magnetic resonance imaging (MRI) has gained increasing importance in the management of
rectal cancer over the last two decades. The role of MRI in patients with rectal cancer has …

Purpose This guideline reviews the evidence and provides recommendations for the
indications and appropriate technique and dose of neoadjuvant radiation therapy (RT) in the …

Background The management of rectal cancer has evolved over the years, including the
recent rise of Transanal Total Mesorectal Excision (TaTME). TaTME addresses the …